Cargando…

Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes

BACKGROUND: When a patient experiences an event other than the one of interest in the study, usually the probability of experiencing the event of interest is altered. By contrast, disease-free survival time analysis by standard methods, such as the Kaplan-Meier method and the standard Cox model, doe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Hyun J, Zhang, Xu, Dyck, Roland, Osgood, Nathaniel
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988010/
https://www.ncbi.nlm.nih.gov/pubmed/20964855
http://dx.doi.org/10.1186/1471-2288-10-97
_version_ 1782192207557558272
author Lim, Hyun J
Zhang, Xu
Dyck, Roland
Osgood, Nathaniel
author_facet Lim, Hyun J
Zhang, Xu
Dyck, Roland
Osgood, Nathaniel
author_sort Lim, Hyun J
collection PubMed
description BACKGROUND: When a patient experiences an event other than the one of interest in the study, usually the probability of experiencing the event of interest is altered. By contrast, disease-free survival time analysis by standard methods, such as the Kaplan-Meier method and the standard Cox model, does not distinguish different causes in the presence of competing risks. Alternative approaches use the cumulative incidence estimator by the Cox models on cause-specific and on subdistribution hazards models. We applied cause-specific and subdistribution hazards models to a diabetes dataset with two competing risks (end-stage renal disease (ESRD) or death without ESRD) to measure the relative effects of covariates and cumulative incidence functions. RESULTS: In this study, the cumulative incidence curve of the risk of ESRD by the cause-specific hazards model was revealed to be higher than the curves generated by the subdistribution hazards model. However, the cumulative incidence curves of risk of death without ESRD based on those three models were very similar. CONCLUSIONS: In analysis of competing risk data, it is important to present both the results of the event of interest and the results of competing risks. We recommend using either the cause-specific hazards model or the subdistribution hazards model for a dominant risk. However, for a minor risk, we do not recommend the subdistribution hazards model and a cause-specific hazards model is more appropriate. Focusing the interpretation on one or a few causes and ignoring the other causes is always associated with a risk of overlooking important features which may influence our interpretation.
format Text
id pubmed-2988010
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29880102010-12-06 Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes Lim, Hyun J Zhang, Xu Dyck, Roland Osgood, Nathaniel BMC Med Res Methodol Research Article BACKGROUND: When a patient experiences an event other than the one of interest in the study, usually the probability of experiencing the event of interest is altered. By contrast, disease-free survival time analysis by standard methods, such as the Kaplan-Meier method and the standard Cox model, does not distinguish different causes in the presence of competing risks. Alternative approaches use the cumulative incidence estimator by the Cox models on cause-specific and on subdistribution hazards models. We applied cause-specific and subdistribution hazards models to a diabetes dataset with two competing risks (end-stage renal disease (ESRD) or death without ESRD) to measure the relative effects of covariates and cumulative incidence functions. RESULTS: In this study, the cumulative incidence curve of the risk of ESRD by the cause-specific hazards model was revealed to be higher than the curves generated by the subdistribution hazards model. However, the cumulative incidence curves of risk of death without ESRD based on those three models were very similar. CONCLUSIONS: In analysis of competing risk data, it is important to present both the results of the event of interest and the results of competing risks. We recommend using either the cause-specific hazards model or the subdistribution hazards model for a dominant risk. However, for a minor risk, we do not recommend the subdistribution hazards model and a cause-specific hazards model is more appropriate. Focusing the interpretation on one or a few causes and ignoring the other causes is always associated with a risk of overlooking important features which may influence our interpretation. BioMed Central 2010-10-21 /pmc/articles/PMC2988010/ /pubmed/20964855 http://dx.doi.org/10.1186/1471-2288-10-97 Text en Copyright ©2010 Lim et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lim, Hyun J
Zhang, Xu
Dyck, Roland
Osgood, Nathaniel
Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes
title Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes
title_full Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes
title_fullStr Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes
title_full_unstemmed Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes
title_short Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes
title_sort methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988010/
https://www.ncbi.nlm.nih.gov/pubmed/20964855
http://dx.doi.org/10.1186/1471-2288-10-97
work_keys_str_mv AT limhyunj methodsofcompetingrisksanalysisofendstagerenaldiseaseandmortalityamongpeoplewithdiabetes
AT zhangxu methodsofcompetingrisksanalysisofendstagerenaldiseaseandmortalityamongpeoplewithdiabetes
AT dyckroland methodsofcompetingrisksanalysisofendstagerenaldiseaseandmortalityamongpeoplewithdiabetes
AT osgoodnathaniel methodsofcompetingrisksanalysisofendstagerenaldiseaseandmortalityamongpeoplewithdiabetes